55 filings
Page 2 of 3
8-K
16eviq 0vyzd9
22 Mar 23
Aziyo Biologics Reports Record Full Year 2022 Revenues
4:06pm
8-K
1kqawq6mgc
20 Mar 23
Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope
5:26pm
8-K
5av1 3kcaib2
9 Jan 23
Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results
8:23am
8-K
d4v6vs6y7zw5qgajb4ae
30 Dec 22
Departure of Directors or Certain Officers
4:06pm
8-K
ue7zg6mse0w6ptf 578r
15 Dec 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:07am
8-K
n8dba1khcl
5 Dec 22
Entry into a Material Definitive Agreement
6:31am
8-K
g7jhbfh
28 Nov 22
Entry into a Material Definitive Agreement
4:56pm
8-K
6x9g 2vwq7y
17 Nov 22
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
1:56pm
8-K
bv8g4 tum38x2c5uq
24 Oct 22
Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors
9:14am
8-K
ty3casohihig936hjqg
13 Oct 22
Entry into a Material Definitive Agreement
5:09pm
8-K
09h1 fifc1rxl7
31 Aug 22
Other Events
4:13pm
8-K
dyji09
15 Aug 22
Entry into a Material Definitive Agreement
4:15pm
8-K
7c3m2s
11 Aug 22
Results of Operations and Financial Condition
4:14pm
8-K
kehomo adtu
21 Jun 22
Aziyo Biologics Appoints DR. C. Randal Mills As Interim President and Ceo
4:15pm
8-K
7ri l1lm4vo4fxu3ghne
8 Jun 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
5o63ktcz0l8mri76o
3 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
gtope
9 May 22
Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results
4:11pm
8-K
q7mkc6 lv2
3 Mar 22
Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results
4:30pm
8-K
kte 0uf3zx
21 Jan 22
Entry into a Material Definitive Agreement
4:53pm
8-K
yf312i 2dv148o
7 Jan 22
Results of Operations and Financial Condition
5:00pm